RetinalGenix Technologies Inc. 8-K

What Happened RetinalGenix Technologies Inc. (filed on March 26, 2026) announced in an 8-K that its Chief Financial Officer, Michael Cory Zwerling, notified the company of his immediate resignation as CFO, effective March 22, 2026.

Key Details

• The company filed Form 8-K on March 26, 2026 reporting the resignation under Item 5.02 (Departure of Directors or Certain Officers).
• Executive who resigned: Michael Cory Zwerling, Chief Financial Officer.
• Resignation effective date: March 22, 2026.
• The filing does not disclose a reason for the resignation or name a successor.

Why It Matters A CFO departure is a material executive change that can affect financial oversight and investor confidence. Because the 8-K provides no reason or replacement, investors should watch for subsequent filings naming an interim or new CFO and any statements about continuity in financial reporting or internal controls. This change may be relevant when evaluating upcoming earnings, financial guidance, or management stability.